Choosing the Right Excipients for the Right Job
July 1, 2019
When it comes to formulation, many choices should be carefully considered – and regulators expect excipient selection to be justified.
0 min read
May 2019
Welcome to the May issue! Medical cannabis and scientific research around cannabinoids is booming, but what does this mean for the pharma industry? Read our feature to find out. Meanwhile, Upfront explores the bioactivity of Actinobacteria found within brown seaweed, and how will the industry shape up over the next five years with an infographic. Heather Zenk argues that blockchain could be one solution to the saleable returns verification aspect of the US Drug Supply Chain Security Act, in In My View; and we tell the story of IPEC's humble beginnings with David Schoneker in Best Practice. Finally, we Sit Down With Robert S. Langer, Pediatrics Polymath, Jinling Chen.
2023: Prices and Predictions
June 5, 2019
How will the industry shape up over the next five years?
0 min read
The IPEC Story: Promoting Ingredients for Success
June 5, 2019
High quality excipients make all the difference to the drug development process. And yet, for years, excipients were often overlooked by the industry. Today, IPEC is helping to give excipients the recognition they deserve.
0 min read
Solutions In... Nanoparticles
May 28, 2019
Chad A. Mirkin, Professor of Chemistry at Northwestern University, discusses why spherical nucleic acids are so exciting for drug development
0 min read
The Killer Combo
May 28, 2019
A longer-lasting strategy to rejuvenate existing antibiotics with synergistic combinations is likely to play an integral role in the development of treatments against antibiotic resistant pathogens.
0 min read
Under Construction: Pharma's Cannabinoid Bid
May 28, 2019
The cannabis business is booming as century-old legal conventions restricting use begin to unravel. Can pharma ride the wave with cannabis-based medicines? And how will drugmakers entering the fray deal with the dosage, delivery and bioavailability challenges?
0 min read
Bright SPARK
May 28, 2019
Academics have a role to play in the acceleration of biomedical innovation. And SPARK, a translational research program at Stanford University is proving how important academicians are in slashing the time taken to bring novel therapeutics to market.
0 min read
Small, But Never Forgotten
May 13, 2019
A new publication will give the small molecule manufacturing community the attention and praise it deserves. Meet The Small Molecule Manufacturer.
0 min read
Treasures of the Deep
May 13, 2019
Could aquatic bacteria hold the keys to bolstering our drug pipelines?
0 min read
Manufacture
Bioprocessing
Biopharma
Regulation & Standards
Facilities & Equipment
Technology & Manufacturing
Sponsored
Built on Innovation
May 13, 2019
Innovation in glass continues to be a key enabler for allowing pharma manufacturers to make better, safer products for patients. This has been SCHOTT’s mantra for more than 130 years – why stop now?
0 min read
Manufacture
Outsourcing
Technology & Manufacturing
Facilities & Equipment
Bioprocessing
Biopharma
Small Molecules
Perks and Pitfalls of Antibody Drug Conjugates
May 13, 2019
ADCs have suffered a few setbacks over the years, but interest in their therapeutic potential – particularly against cancer – remains high.
0 min read
Business & Regulation
Outsourcing
Technology & Manufacturing
Supply Chain
Regulation & Standards
Business & Trends
(Block)chain Reaction
May 7, 2019
Blockchain could be one solution to the saleable returns verification aspect of the US’ Drug Supply Chain Security Act.
0 min read
Pediatrics Polymath
May 7, 2019
Sitting Down With… Jinling Chen, Vice President, Pharmaceutical Development Services, WuXi STA, China.
0 min read
Business in Brief
May 9, 2018
A knockback for biosimilars in the US, patient engagement, and contaminated blood products… What’s new for pharma in business?
1 min read
